RXi Pharmaceuticals Granted Patents for sd-rxRNA Technology Strengthening Intellectual Property Estate in Europe and Japan

MARLBOROUGH, Mass., Aug. 2, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its prop…
( read original story …)


Related Post

Conrad Osaka Hotel Opens in Japan
views 201
The Conrad Hotels & Resorts brand celebrates furth...
Live Like a Modern Day Emperor and Experience the ...
views 143
But since we can’t move into Japan’s Imperial Pala...
Tokyo stocks rally on weak yen
views 40
Tokyo: Tokyo stocks rose for a third straight sess...
Italian satellite launcher Avio gains 6.6% in IPO ...
views 220
They include countries such as Peru and Vietnam, b...
Global shares mixed; Japan benchmark falls on weak...
views 162
ASIA'S DAY: Japan's benchmark Nikkei 225 inched do...
Japan October exports fall more than expected as s...
views 205
TOKYO Japan's exports fell in October for a 13th c...
Japan insurer Aioi Nissay eyes alternative assets,...
views 72
Aioi Nissay Dowa is the non-life insurance arm of ...
Nikkei rises on weak yen, stimulus hopes; exporter...
views 134
TOKYO, Sept 25 (Reuters) - Japan’s Nikkei share av...
He served in Vietnam. His homeowner’s assocation o...
views 165
His Navy career helped him see the world and meet ...
Osaka hospital steps up under new autopsy law to e...
views 195
OSAKA – A hospital in Osaka began performing autop...